Fixed Income Futures
Fixed Income Options
STIR Futures & Options
Credit Index Futures
Financing of Futures CTDs
STOXX
MSCI
FTSE
DAX
Mini-DAX
Micro Product Suite
Daily Options
Index Total Return Futures
ESG Index Derivatives
Country Indexes
KOSPI
Exchange Participants
Market Maker Futures
Market Maker Options
ISV & service provider
3rd Party Information Provider
Market data vendors
Brokers
Multilateral and Brokerage Functionality
Block Trades
Delta TAM
T7 Entry Service via e-mail
Vola Trades
Additional contract versions
Exchange for Physicals
Trade at Index Close
Exchange for Swaps
Non-disclosure facility
Market statistics (online)
Trading statistics
Monthly statistics
Eurex Repo statistics
Snapshot summary report
Product parameter files
T7 Entry Service parameters
EFS Trades
EFP-Fin Trades
EFP-Index Trades
MiFID2 Commodity Derivatives Instruments
Total Return Futures conversion parameters
Product and Price Report
Variance Futures conversion parameters
Suspension Reports
Position Limits
File service agreement
Current traded series delta version
Prices Rolling Spot Future
Notified Bonds | Deliverable Bonds and Conversion Factors
Risk parameters and initial margins
Securities margin groups and classes
Haircut and adjusted exchange rate
Cross-Project-Calendar
Readiness for projects
Readiness for products
T7 Release 13.0
T7 Release 12.1
T7 Release 12.0
T7 Release 11.1
Member Section Releases
Simulation calendar
Archive
Connectivity
Independent Software Vendors
Implementation News
Simulation Calender
F7 General FAQ
F7 MiFID II FAQ
Direct market access from the U.S.
Eligible options under SEC class No-Action Relief
Eligible foreign security futures products under 2009 SEC Order and Commodity Exchange Act
U.S. Introducing Broker direct Eurex access
MiFID II/MiFIR
PRIIPs/KIDs
IBOR Reform
Capital Markets Union
Order-to-Trade Ratio
Excessive System Usage Fee
The company Eckert & Ziegler SE has announced to spin off its radiopharmaceuticals business bundled in the company Pentixapharm AG for absorption by Pentixapharm Holding AG. Shareholders of Eckert & Ziegler SE shall be entitled to receive for every one share held one share of Pentixapharm Holding AG.
More information about this transaction is available on www.pentixapharm.com.
Update as of 26.09.2024 (Product ISIN new / Underlying ISIN new provided):
Product code | Product code | Product ISIN old | Product ISIN new | Underlying ISIN old | Underlying-ISIN new | Name old | Name new |
EUZ | EUZB | DE0005659700 | DE000A4AJNN7 | DE0005659700 | DE000A4AJNN7 | Opt on Eckert & Ziegler | Opt on Eckert & Ziegler and Pentixapharm Holding Basket |
Market Status ⓘ
XEUR
The market status window is an indication regarding the current technical availability of the trading system. It indicates whether news board messages regarding current technical issues of the trading system have been published or will be published shortly.
Please find further information about incident handling in the Emergency Playbook published on the Eurex webpage under Support --> Emergencies and safeguards. Detailed information about incident communication, market re-opening procedures and best practices for order and trade reconciliation can be found in the chapters 4.2, 4.3 and 4.5, respectively. Concrete information for the respective incident will be published during the incident via newsboard message.
We strongly recommend not to take any decisions based on the indications in the market status window but to always check the production news board for comprehensive information on an incident.
An instant update of the Market Status requires an enabled up-to date Java™ version within the browser.